MENU
ENLV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Enlivex (ENLV) Ownership - Who owns Enlivex?

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis... Show more

Profile

Industry
Medical Specialties
Address
14 Einstein Street
Phone
+972 86328500
Employees
34
Web
https://www.enlivex.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
204.87M
P/E Ratio
0.03
Total Cash
18.2M
Projected Growth
N/A
Total Debt
701K
Revenue
N/A
Risk (Beta)
2.56
Dividend Yield
N/A
Total Cash/Share
0.08
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
ENLV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

Industry Biotechnology

Profile
Details
Industry
Medical Specialties
Address
14 Einstein Street
Phone
+972 86328500
Employees
34
Web
https://www.enlivex.com